• Mouse Periostin/PN/POSTN protein (Recombinant) (C-6His) (STJP001937)

Mouse Periostin/PN/POSTN protein (Recombinant) (C-6His) (STJP001937)

SKU:
STJP001937

Current Stock:
Host: HEK293 cells
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Mouse Periostin/PN/POSTN-C-6His protein was developed from hek293 cells and has a target region of C-6His. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: Postn
Gene ID: 50706
Uniprot ID: POSTN_MOUSE
Immunogen Region: Asn24-Gln811
Immunogen: Recombinant Mouse Periostin/PN/POSTN Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Asn24-Gln811) of mouse Periostin/PN/POSTN (Accession #NP_056599.1) fused with a 6×His tag at the C-terminus.
Post Translational Modifications Gamma-carboxylation is controversial. Gamma-carboxyglutamated.gamma-carboxyglutamate residues are formed by vitamin K dependent carboxylation.these residues may be required for binding to calcium. According to a more recent report in human, does not contain vitamin K-dependent gamma-carboxyglutamate residues.
Function Induces cell attachment and spreading and plays a role in cell adhesion. Enhances incorporation of BMP1 in the fibronectin matrix of connective tissues, and subsequent proteolytic activation of lysyl oxidase LOX.
Protein Name Periostin
Pn
Osteoblast-Specific Factor 2
Osf-2
Cellular Localisation Golgi Apparatus
Secreted
Extracellular Space
Extracellular Matrix
Colocalizes With Bmp1 In The Golgi
Alternative Protein Names Periostin protein
Pn protein
Osteoblast-Specific Factor 2 protein
Osf-2 protein
Postn protein
Osf2 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance